In a viral hemorrhagic disease where up to 40 percent of people developing it die, it is remarkable that doctors still do not agree whether the only recognized treatment, an antiviral drug called ribavirin, makes a difference.
In a viral hemorrhagic disease where up to 40 percent of people developing it die, it is remarkable that doctors still do not agree whether the only recognized treatment, an antiviral drug called ribavirin, makes a difference.